Search Results for: Dry Eye Syndrome A Review
Articles
FORMULATION FORUM - Nanoparticle Technologies Used in Ocular Drug Delivery February 29, 2024
Shaukat Ali, PhD, and Jim Huang, PhD, describe the basic understanding of eye diseases, challenges in ocular drug delivery, and the future trends in development of innovative drugs.
CLINICAL TRIALS SOLUTIONS - Cracking Down on the Rising Costs of Drug Development: How Pinpointing the Complexity of Individual Patients Can Improve Success Rates June 1, 2022
Dominique Demolle, PhD, and Erica Smith, PhD, say taking a more holistic, patient-centric approach by considering patients’ individual psychology, perceptions, and beliefs provides drug developers the opportunity to quantify these interpersonal differences between patients and address this source of variability in data analysis and interpretation.
A New Generation of Ophthalmic Products With Pylote Eco-Friendly Protection Offers Improved Safety & Comfort for Patients October 5, 2018
Like all pharmaceuticals, ophthalmic preparations are subject to microbiological contamination. Both ophthalmic solutions used for diagnostic and therapeutic purposes have been found to be contaminated by pathogenic bacteria with reported rates as high as 70%, associated with severe ocular infections such as keratitis and endophthalmitis.
Catalyst Pharmaceutical Partners Gets Breakthrough Therapy Designation, Stock Soars 41.55% September 4, 2013
Catalyst Pharmaceutical Partners, Inc. recently announced its investigational product Firdapse (amifampridine phosphate) has received Breakthrough Therapy Designation by the US...Issues
October 2012
COVER DRUG DEVICES – The Rise of the Bolus Injector – A New Device Class Enabling Long-Duration Subcutaneous Administration of...
